Form 8-K - Current report:
SEC Accession No. 0000891618-99-002576
Filing Date
1999-06-04
Accepted
1999-06-04 00:00:00
Documents
4
Period of Report
1999-06-03
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K 8-K 5030
2 SUBSCRIPTION, JOINT DEVELOPMENT, OPERATING AGRMT. EX-10.58 130125
3 LICENSE AGREEMENT (CELTRIX NEWCO/CELTRIX PHARM.) EX-10.59 76605
4 LICENSE AGREEMENT (CELTRIX NEWCO/ELAN PHARM.) EX-10.60 74726
  Complete submission text file 0000891618-99-002576.txt   288443
Mailing Address 2033 GATEWAY PLACE SUITE 600 SAN JOSE CA 95110
Business Address 2033 GATEWAY PLACE SUITE 600 SAN JOSE CA 95110 4089882500
CELTRIX PHARMACEUTICALS INC (Filer) CIK: 0000871395 (see all company filings)

EIN.: 943121462 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-18976 | Film No.: 99640682
SIC: 2834 Pharmaceutical Preparations